NCT02561507

Brief Summary

This is a survey of members of the American College of Surgeons (ACS), to describe and explore current patterns of their decisions about withholding or continuation for patients taking aspirin (ASA) in the perioperative period. Secondarily, the survey will also explore surgeons' knowledge about the risks and benefits attending this decision, and about national organizations' recommendations.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2015

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 24, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 28, 2015

Completed
3 days until next milestone

Study Start

First participant enrolled

October 1, 2015

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2016

Completed
Last Updated

January 8, 2024

Status Verified

January 1, 2024

Enrollment Period

6 months

First QC Date

September 24, 2015

Last Update Submit

January 4, 2024

Conditions

SurgeryCardiovascular Disease

Outcome Measures

Primary Outcomes (3)

  • Typical proportion of participants' patients given a recommendation to stop taking aspirin

    At time of survey; generally less than 20 minutes

  • Proportion of participants correctly identifying national organizations with perioperative aspirin recommendations

    At time of survey; generally less than 20 minutes

  • Proportion of participants correctly answering questions about platelet rebound effect

    At time of survey; generally less than 20 minutes

Study Arms (1)

American College of Surgeons members

Survey participants

Behavioral: Survey

Interventions

SurveyBEHAVIORAL
American College of Surgeons members

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Members of the American College of Surgeons

You may qualify if:

  • Members of the American College of Surgeons

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of New Mexico Hospital

Albuquerque, New Mexico, 87106, United States

Location

MeSH Terms

Conditions

Cardiovascular Diseases

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Neal Gerstein, MD

    University of New Mexico

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 24, 2015

First Posted

September 28, 2015

Study Start

October 1, 2015

Primary Completion

April 1, 2016

Study Completion

May 1, 2016

Last Updated

January 8, 2024

Record last verified: 2024-01

Locations

US(1)